MENU
KTTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pasithea Therapeutics (KTTA) Ownership - Who owns Pasithea Therapeutics?
Profile
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 702 514-4174
Employees
8
Web
https://www.pasithea.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.5M
P/E Ratio
N/A
Total Cash
9.36M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.82
Dividend Yield
N/A
Total Cash/Share
7.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KTTA
Capitalization
3.5M
P/E Ratio
N/A
Risk (Beta)
0.82
Dividend Yield
N/A
Total Cash
9.36M
Total Cash/Share
7.39
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
17.8M
P/B Ratio
0.19
Cash Flow
N/A
Earnings
-14.82
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
104
Current Ratio
14.81
Current Revenue Per Employee
16047.47
Dividends Per Share - Security
N/A
EBITDA
-15.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.54
Revenue To Assets
-64.00
Shares Held By Institutions
194K
Shares Outstanding - Current
1.27M
Total Liabilities
824K
Total Volume MTD
N/A
Value
1
Gain YTD
-64.459
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 702 514-4174
Employees
8
Web
https://www.pasithea.com